Cargando…
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies
BACKGROUND: Pancreatic cancer is one of the most lethal of human malignancies known to date and shows relative insensitivity towards most of the clinically available therapy regimens. 3,5-bis(2-fluorobenzylidene)-4-piperidone (EF24), a novel synthetic curcumin analog, has shown promising in vitro th...
Autores principales: | Bisht, Savita, Schlesinger, Martin, Rupp, Alexander, Schubert, Rolf, Nolting, Jens, Wenzel, Jörg, Holdenrieder, Stefan, Brossart, Peter, Bendas, Gerd, Feldmann, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940769/ https://www.ncbi.nlm.nih.gov/pubmed/27401816 http://dx.doi.org/10.1186/s12951-016-0209-6 |
Ejemplares similares
-
EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
por: Bisht, Savita, et al.
Publicado: (2019) -
The curcumin analog EF24 is a novel senolytic agent
por: Li, Wen, et al.
Publicado: (2019) -
Bioactivities of EF24, a Novel Curcumin Analog: A Review
por: He, Yonghan, et al.
Publicado: (2018) -
In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog
por: Liu, Haitao, et al.
Publicado: (2012) -
The Curcumin Analog EF24 Targets NF-κB and miRNA-21, and Has Potent Anticancer Activity In Vitro and In Vivo
por: Yang, Chuan He, et al.
Publicado: (2013)